285 related articles for article (PubMed ID: 36150158)
1. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.
Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R
Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158
[TBL] [Abstract][Full Text] [Related]
2. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
3. Alternating pattern of rhino-orbital-cerebral mucormycosis with COVID-19 in diabetic patients.
Eker C; Tarkan O; Surmelioglu O; Dagkiran M; Tanrisever I; Yucel Karakaya SP; Ulas B; Onan E; Uguz AH; Ozdemir S
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):219-226. PubMed ID: 35768700
[TBL] [Abstract][Full Text] [Related]
4. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
6. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
[TBL] [Abstract][Full Text] [Related]
8. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
Mitra S; Janweja M; Sengupta A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
[TBL] [Abstract][Full Text] [Related]
9. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
10. Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study.
Gandhi A; Narula A; Chandra S; Agarwal D; Mehta A; Nayak S; Arora S; Capoor MR
Int Ophthalmol; 2023 May; 43(5):1571-1580. PubMed ID: 36273362
[TBL] [Abstract][Full Text] [Related]
11. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
[TBL] [Abstract][Full Text] [Related]
12. COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.
Moorthy A; Nayak T; Bachalli PS; Tripathi KK; Dutt SN; Kale P; Bhat P; Suresh PK; Gaikwad R; Raju A; Krishna S; Conjeevaram A; Mehta S; Anil-Kumar A; Haldipur D
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):713-721. PubMed ID: 35849188
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of orbital apex syndrome in COVID associated mucormycosis patients in a tertiary care hospital.
Srivastava SR; Ganguly P; Barman D; Das S; Bandyopadhyay M; Ghosh AK; Sarkar S; Sengupta A; Swaika S; Chatterjee P; Gupta AK; Mondal AR; Guha S; Dutta S; Adhikari S; Kaushik A; Biswas PS; Ayub A
Int J Ophthalmol; 2022; 15(4):527-532. PubMed ID: 35450177
[TBL] [Abstract][Full Text] [Related]
14. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
18. Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.
Fatima N; Ahmed S; Shameem M; Ahmed A; Hasan W; Khan PA
Indian J Med Microbiol; 2023; 46():100467. PubMed ID: 37651764
[TBL] [Abstract][Full Text] [Related]
19. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
[TBL] [Abstract][Full Text] [Related]
20. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
